Inhibition of herpes simplex virus type 1, respiratory syncytial virus and echovirus type 11 by peroxidase-generated hypothiocyanite.
about
Molecular heterogeneity and alternative splicing of human lactoperoxidaseEffect of lactoperoxidase on the antimicrobial effectiveness of the thiocyanate hydrogen peroxide combination in a quantitative suspension test.Topical antimicrobials for burn infections - an updateHuman salivary cystatin SA exhibits antimicrobial effect against Aggregatibacter actinomycetemcomitans.Salivary histatin 5 and its similarities to the other antimicrobial proteins in human saliva.Antimicrobial agents in saliva--protection for the whole body.Evaluation of the prevalence of herpes simplex-1 infection in oral squamous cell carcinoma specimens in Alzahra and Kashani Hospitals with polymerase chain reaction method in 2012-2013.Biochemical and pathological studies on peroxidases -an updated review.Selective metabolism of hypothiocyanous acid by mammalian thioredoxin reductase promotes lung innate immunity and antioxidant defenseNebulized thiocyanate improves lung infection outcomes in mice.Biochemical mechanisms and therapeutic potential of pseudohalide thiocyanate in human health.Evidences suggesting involvement of viruses in oral squamous cell carcinoma.The role of hypothiocyanous acid (HOSCN) in biological systems.Thiocyanate: a potentially useful therapeutic agent with host defense and antioxidant properties.Lactoperoxidase: structural insights into the function,ligand binding and inhibition.Lung epithelial NOX/DUOX and respiratory virus infections.Comparative Analysis of the Antiviral Activity of Camel, Bovine, and Human Lactoperoxidases Against Herpes Simplex Virus Type 1.IFNβ/TNFα synergism induces a non-canonical STAT2/IRF9-dependent pathway triggering a novel DUOX2 NADPH oxidase-mediated airway antiviral response.Hypothiocyanite produced by human and rat respiratory epithelial cells inactivates extracellular H1N2 influenza A virus.Longitudinal analysis of the association of human salivary antimicrobial agents with caries increment and cariogenic micro-organisms: a two-year cohort study.Oral shedding of herpes simplex virus type 1: a review.Why whey? Camel whey protein as a new dietary approach to the management of free radicals and for the treatment of different health disorders.Eosinophil peroxidase oxidation of thiocyanate. Characterization of major reaction products and a potential sulfhydryl-targeted cytotoxicity system.Salivary defense factors in herpes simplex virus infection.Detection of herpes simplex virus type 1 shedding in the oral cavity by polymerase chain reaction and enzyme-linked immunosorbent assay at the prodromal stage of recrudescent herpes labialis.Potential antiviral activities of camel, bovine, and human lactoperoxidases against hepatitis C virus genotype 4
P2860
Q24322001-84963A61-7D23-442D-837D-554F85B98DD8Q33480302-FF5D40A6-EA02-4E83-8407-AD7AB94DD258Q33600002-056F588E-9A09-4DC6-8F95-E17BC13649D8Q34267868-68708DF2-E527-492F-AB08-D43E44DC2250Q34528899-E36FD0D5-449D-4BC1-8821-3E14569D0C21Q35009873-A3FB887E-5364-4E7B-96AB-462A8E8C4225Q36196383-C4B19B76-C6F9-4FB9-85DC-64E7EF9F2CF7Q36780282-CBB21183-B854-4966-9E16-9770AD836099Q36947849-856768C4-9721-46DB-B387-594DC06CBE96Q36965928-C01C2EB5-4444-4CB6-9F2E-262CDE412D27Q37122833-9467CCBC-13F1-41BE-8E89-57204D3453B9Q37433327-61B1F707-64E7-4A31-8CEF-7535489E8706Q37631070-03129673-446E-4850-8A36-078C79D96659Q37698415-C55575B6-1E0D-4F99-95E3-485CC84C250EQ38139409-BBE49A22-AB00-4DCC-90CF-9808CC5F2BE1Q38279714-34A71162-23CA-4CD0-BBEB-25CEEBE9708FQ38730749-36BC1D31-B94A-4310-8C88-24ABE88FD464Q39172917-4245FFB2-C1FB-4CD3-BD05-0ADDB6A60F68Q40273625-CA28AA59-6204-4629-97BA-BE825908156CQ40872404-5EBF5ECB-9083-4E92-A4AA-38156615BC51Q41673268-EF0211C2-B679-43D5-9B26-B21F177E477EQ41877536-014F8F0C-A65E-41BB-B363-EDA9819AF977Q43507730-4CB02EAB-9FAB-4613-907B-202130880095Q45731893-9E57784E-F1BE-4BA6-A8E8-2AB0C1E4B3EEQ45761287-C93D2FD4-67E4-4F92-B64D-BC218E42A2CBQ58449674-0901A098-7019-4FAA-93E4-20ABF2D7CF7B
P2860
Inhibition of herpes simplex virus type 1, respiratory syncytial virus and echovirus type 11 by peroxidase-generated hypothiocyanite.
description
1995 nî lūn-bûn
@nan
1995 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի մարտին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Inhibition of herpes simplex v ...... ase-generated hypothiocyanite.
@ast
Inhibition of herpes simplex v ...... ase-generated hypothiocyanite.
@en
Inhibition of herpes simplex v ...... ase-generated hypothiocyanite.
@nl
type
label
Inhibition of herpes simplex v ...... ase-generated hypothiocyanite.
@ast
Inhibition of herpes simplex v ...... ase-generated hypothiocyanite.
@en
Inhibition of herpes simplex v ...... ase-generated hypothiocyanite.
@nl
prefLabel
Inhibition of herpes simplex v ...... ase-generated hypothiocyanite.
@ast
Inhibition of herpes simplex v ...... ase-generated hypothiocyanite.
@en
Inhibition of herpes simplex v ...... ase-generated hypothiocyanite.
@nl
P1433
P1476
Inhibition of herpes simplex v ...... dase-generated hypothiocyanite
@en
P2093
P304
P356
10.1016/0166-3542(94)00073-H
P577
1995-03-01T00:00:00Z